PRESS RELEASE, December 6th 2022
TRiCares Successfully Closes Series C Financing, Raising €51m to Fund
TRiCares Successfully Closes Series C Financing, Raising €51m to Fund
Further Development and Clinical Trials of Minimally Invasive
Treatment for Tricuspid Regurgitation